Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.

Buhrmann C, Yazdi M, Popper B, Kunnumakkara AB, Aggarwal BB, Shakibaei M.

Nutrients. 2019 Mar 26;11(3). pii: E704. doi: 10.3390/nu11030704.

2.

Evidence that TNF-β induces proliferation in colorectal cancer cells and resveratrol can down-modulate it.

Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M.

Exp Biol Med (Maywood). 2019 Jan;244(1):1-12. doi: 10.1177/1535370218824538. Epub 2019 Jan 19.

PMID:
30661394
3.

Resveratrol Chemosensitizes TNF-β-Induced Survival of 5-FU-Treated Colorectal Cancer Cells.

Buhrmann C, Yazdi M, Popper B, Shayan P, Goel A, Aggarwal BB, Shakibaei M.

Nutrients. 2018 Jul 12;10(7). pii: E888. doi: 10.3390/nu10070888.

4.

Resveratrol downregulates inflammatory pathway activated by lymphotoxin α (TNF-β) in articular chondrocytes: Comparison with TNF-α.

Buhrmann C, Popper B, Aggarwal BB, Shakibaei M.

PLoS One. 2017 Nov 2;12(11):e0186993. doi: 10.1371/journal.pone.0186993. eCollection 2017.

5.

Resveratrol Regulates Colorectal Cancer Cell Invasion by Modulation of Focal Adhesion Molecules.

Buhrmann C, Shayan P, Goel A, Shakibaei M.

Nutrients. 2017 Sep 27;9(10). pii: E1073. doi: 10.3390/nu9101073.

6.

Sirt1 Is Required for Resveratrol-Mediated Chemopreventive Effects in Colorectal Cancer Cells.

Buhrmann C, Shayan P, Popper B, Goel A, Shakibaei M.

Nutrients. 2016 Mar 5;8(3):145. doi: 10.3390/nu8030145.

7.

Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.

Buhrmann C, Shayan P, Kraehe P, Popper B, Goel A, Shakibaei M.

Biochem Pharmacol. 2015 Nov 1;98(1):51-68. doi: 10.1016/j.bcp.2015.08.105. Epub 2015 Aug 24.

PMID:
26310874
8.

Curcumin potentiates antitumor activity of 5-fluorouracil in a 3D alginate tumor microenvironment of colorectal cancer.

Shakibaei M, Kraehe P, Popper B, Shayan P, Goel A, Buhrmann C.

BMC Cancer. 2015 Apr 10;15:250. doi: 10.1186/s12885-015-1291-0.

9.

Novel Evidence for Curcumin and Boswellic Acid-Induced Chemoprevention through Regulation of miR-34a and miR-27a in Colorectal Cancer.

Toden S, Okugawa Y, Buhrmann C, Nattamai D, Anguiano E, Baldwin N, Shakibaei M, Boland CR, Goel A.

Cancer Prev Res (Phila). 2015 May;8(5):431-43. doi: 10.1158/1940-6207.CAPR-14-0354. Epub 2015 Feb 23.

10.

Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer.

Toden S, Okugawa Y, Jascur T, Wodarz D, Komarova NL, Buhrmann C, Shakibaei M, Boland CR, Goel A.

Carcinogenesis. 2015 Mar;36(3):355-67. doi: 10.1093/carcin/bgv006. Epub 2015 Feb 4.

11.

Curcumin suppresses crosstalk between colon cancer stem cells and stromal fibroblasts in the tumor microenvironment: potential role of EMT.

Buhrmann C, Kraehe P, Lueders C, Shayan P, Goel A, Shakibaei M.

PLoS One. 2014 Sep 19;9(9):e107514. doi: 10.1371/journal.pone.0107514. eCollection 2014.

12.

Sirtuin-1 (SIRT1) is required for promoting chondrogenic differentiation of mesenchymal stem cells.

Buhrmann C, Busch F, Shayan P, Shakibaei M.

J Biol Chem. 2014 Aug 8;289(32):22048-62. doi: 10.1074/jbc.M114.568790. Epub 2014 Jun 24.

13.

Curcumin chemosensitizes 5-fluorouracil resistant MMR-deficient human colon cancer cells in high density cultures.

Shakibaei M, Buhrmann C, Kraehe P, Shayan P, Lueders C, Goel A.

PLoS One. 2014 Jan 3;9(1):e85397. doi: 10.1371/journal.pone.0085397. eCollection 2014.

14.

Evidence that TNF-β (lymphotoxin α) can activate the inflammatory environment in human chondrocytes.

Buhrmann C, Shayan P, Aggarwal BB, Shakibaei M.

Arthritis Res Ther. 2013;15(6):R202.

16.

Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation.

Shakibaei M, Shayan P, Busch F, Aldinger C, Buhrmann C, Lueders C, Mobasheri A.

PLoS One. 2012;7(4):e35712. doi: 10.1371/journal.pone.0035712. Epub 2012 Apr 23.

17.

IGF-1 and PDGF-bb suppress IL-1β-induced cartilage degradation through down-regulation of NF-κB signaling: involvement of Src/PI-3K/AKT pathway.

Montaseri A, Busch F, Mobasheri A, Buhrmann C, Aldinger C, Rad JS, Shakibaei M.

PLoS One. 2011;6(12):e28663. doi: 10.1371/journal.pone.0028663. Epub 2011 Dec 14.

18.

Anti-inflammatory and anti-catabolic effects of TENDOACTIVE® on human tenocytes in vitro.

Shakibaei M, Buhrmann C, Mobasheri A.

Histol Histopathol. 2011 Sep;26(9):1173-85. doi: 10.14670/HH-26.1173.

PMID:
21751149
19.

Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway.

Buhrmann C, Mobasheri A, Busch F, Aldinger C, Stahlmann R, Montaseri A, Shakibaei M.

J Biol Chem. 2011 Aug 12;286(32):28556-66. doi: 10.1074/jbc.M111.256180. Epub 2011 Jun 13.

20.

Curcumin synergizes with resveratrol to stimulate the MAPK signaling pathway in human articular chondrocytes in vitro.

Shakibaei M, Mobasheri A, Buhrmann C.

Genes Nutr. 2011 May;6(2):171-9. doi: 10.1007/s12263-010-0179-5. Epub 2010 May 25.

21.

Three-dimensional high-density co-culture with primary tenocytes induces tenogenic differentiation in mesenchymal stem cells.

Schneider PR, Buhrmann C, Mobasheri A, Matis U, Shakibaei M.

J Orthop Res. 2011 Sep;29(9):1351-60. doi: 10.1002/jor.21400. Epub 2011 Mar 15.

22.

Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancer.

Harter P, Muallem ZM, Buhrmann C, Lorenz D, Kaub C, Hils R, Kommoss S, Heitz F, Traut A, du Bois A.

Gynecol Oncol. 2011 Jun 1;121(3):615-9. doi: 10.1016/j.ygyno.2011.02.014. Epub 2011 Mar 17.

PMID:
21414656
23.
24.

Re-operation outcome in patients referred to a gynecologic oncology center with presumed ovarian cancer FIGO I-IIIA after sub-standard initial surgery.

Grabowski JP, Harter P, Buhrmann C, Lorenz D, Hils R, Kommoss S, Traut A, du Bois A.

Surg Oncol. 2012 Mar;21(1):31-5. doi: 10.1016/j.suronc.2010.08.006. Epub 2010 Sep 27.

PMID:
20875732
25.

Curcumin mediated suppression of nuclear factor-κB promotes chondrogenic differentiation of mesenchymal stem cells in a high-density co-culture microenvironment.

Buhrmann C, Mobasheri A, Matis U, Shakibaei M.

Arthritis Res Ther. 2010;12(4):R127. doi: 10.1186/ar3065. Epub 2010 Jul 1.

26.

Para-aortic lymph node metastasis in malignant dysgerminoma of the ovary.

Kasenda B, Harter P, Hirsch T, Ast A, Buhrmann C, Glaser F, Du Bois A.

Acta Obstet Gynecol Scand. 2009;88(11):1288-90. doi: 10.3109/00016340903242461.

PMID:
19900144
27.

Impact of treatment guidelines and implementation of a quality assurance program on quality of care in endometrial cancer.

du Bois A, Strutas D, Buhrmann C, Traut A, Ewald-Riegler N, Kommoss S, Gomez R, Harter P.

Onkologie. 2009 Sep;32(8-9):493-8. doi: 10.1159/000226146. Epub 2009 Jul 31.

PMID:
19745593
28.

Compliance to consensus recommendations, surgeon's experience, and introduction of a quality assurance and management program: influence on therapy of early-stage ovarian carcinoma.

Kommoss S, Harter P, Traut A, Strutas D, Riegler N, Buhrmann C, Gomez R, du Bois A.

Int J Gynecol Cancer. 2009 May;19(4):787-93. doi: 10.1111/IGC.0b013e3181a3a551.

PMID:
19509589
29.

Incidence, prevalence, and clinical outcome of hepatitis GB-C virus infection in liver transplant patients.

Kallinowski B, Buhrmann C, Seipp S, Goeser T, Stremmel W, Otto G, Theilmann L.

Liver Transpl Surg. 1998 Jan;4(1):28-33.

Supplemental Content

Loading ...
Support Center